Bavarian Biotech Report 2011/2012 (7MB) - Bio M
Bavarian Biotech Report 2011/2012 (7MB) - Bio M Bavarian Biotech Report 2011/2012 (7MB) - Bio M
Contact:Dr. Gundel HagerBahnhofstr. 9-15D-82327 TutzingPhone: +49 (0) 8158 2597-30Fax: +49 (0) 8158 2597-31E-Mail: info@aurigon.deInternet: www.aurigon.deAurigon Life Science GmbHBIOTECH PRECLINICAL SERVICESKeywords: Toxicology, Pharmacology, Drug DevelopmentAurigon the CRO for efficacy and safety testing, is an independent, privatelyowned company dedicated to serving the biotech, pharmaceutical, food andchemical industries by providing a comprehensive range of services in bioanalytics,pharmacology, biological activity testing, ADME/PK and regulatorytoxicology (rodent and non-rodent) including genotoxicity, immunotoxicity,safety pharmacology, cancerogenicity and reprotoxicity. We have broadexperience in working with small molecules, chemicals and biologicals includingpeptides, antibodies, biosimilars, herbal extracts, nutritionals and celltherapy. With personalized and flexible services we support achievement ofour customers needs in expected timelines, investment and efforts. With itsheadquarter in the south of Munich, Aurigon Life Science operates in state ofthe art GLP respectively GMP compliant facilities with subsidiary andaffiliated laboratories located near Budapest. We are a trusted outsourcingpartner for multinational pharmaceutical and chemical groups, food producersand innovative biotechnology companies. We feel committed to life.baseclick GmbHBIOTECH DEVICES & REAGENTSContact:Dr. Thomas FrischmuthBahnhofstr. 9-15D-82327 TutzingPhone: +49 (0) 8158 903867Fax: +49 (0) 8158 903894E-Mail: info@baseclick.euInternet: www.baseclick.euKeywords: Clinical Diagnostics, Fine Chemicals / Reagents, New Materials,Chip / Array Technology, Nanobiotechnology, PCRbaseclick GmbH is a young and dynamic company funded and founded byBASF Venture Capital GmbH. The baseclick IP was generated at the Universityof Munich in the group of Prof. Thomas Carell. Core technology of ourcompany is the modification of nucleic acids via click chemistry. baseclickholds the IP for the technology and offers this for licensing, purchasing ofour products, and cooperation for the further development. We provideinnovative products to improve and enhance your research in the fields of:Oligonucleotide-, DNA- and RNA-labeling; PCR assays, cell proliferationassays, FISH probes and many more.Basilea Pharmaceutica Deutschland GmbHPHARMA & CHEMICAL INDUSTRYContact:Dr. Thomas TrillingKistlerhofstr. 75D-81379 MünchenPhone: +49 (0) 89 7857674-0Fax: +49 (0) 89 7857674-100E-Mail: office.DE@basileapharma.comInternet: www.basilea.com40Keywords: Drug Development, Antibiotics, Allergy, Dermatology, InfectiousDiseases, OncologyBasilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland. Thecompany currently focuses on antibiotics and antifungal as well as oncologyand dermatology drugs, targeting the medical challenge of rising resistanceand non-response to current treatment options in the hospital and specialtycare settings. Basilea Pharmaceutica Deutschland was founded 2007 inMunich. Skin diseases are an area of high medical need. Patients aresuffering from disfiguring conditions such as hand eczema. Alitretinoin(Toctino ® ), a vitamin A derivative offers a significant quality of life improvementin the treatment of adults with severe chronic hand eczema unresponsiveto topical corticosteroid.
Bavarian Nordic GmbHBIOTECH THERAPEUTICS & DIAGNOSTICSKeywords: Infectious Diseases, Vaccines, Drug DevelopmentBavarian Nordic (BN) is a leading international biopharmaceutical companydeveloping innovative vaccines to prevent and treat infectious diseases. Thecompany is capable to meet the growing demand for safe 3rd generationsmallpox vaccines due to its proprietary vaccine technology MVA-BN ® . BNwas founded in 1994 and is headquartered in Kvistgaard, Denmark with subsidiaryoperations in Martinsried and Berlin, Germany. BN recently foundedin the US an operating company, BN ImmunoTherapeutics Inc., for researchand development of cancer vaccines. The company employs about 180 peopleand is listed on the Copenhagen Stock Exchange.More than 450 healthy and immune compromised subjects so far vaccinatedwith MVA-BN ® , suggest an excellent safety and efficacy profile of thevector.Contact:Derek BeggsFraunhoferstr. 13D-82152 MartinsriedPhone: +49 (0) 89 85650030Fax: +49 (0) 89 85651333E-Mail: derek.beggs@bavarian-nordic.comInternet: www.bavarian-nordic.comBaxter Deutschland GmbHPHARMA & CHEMICAL INDUSTRYKeywords: Tissue Engineering / Cell Culture, Vaccines, Immune Therapy, Pain,Oncology, Autoimmune Diseases, NephrologyBaxter International Inc. (NYSE: BAX), through its subsidiaries, develops,manufactures and markets products that save and sustain the lives of peoplewith hemophilia, immune disorders, infectious diseases, kidney disease,trauma, and other chronic and acute medical conditions. As a global, diversifiedhealthcare company, Baxter applies a unique combination of expertisein medical devices, pharmaceuticals and biotechnology to create productsthat advance patient care worldwide.Contact:Lutz KnabeEdisonstr. 4D-85716 UnterschleißheimPhone: +49 (0) 89 31701-0Fax: +49 (0) 89 31701-277E-Mail: info_de@baxter.comInternet: www.baxter.deBeckman Coulter Biomedical GmbHBIOTECH DEVICES & REAGENTSKeywords: Devices, Nanobiotechnology, Automation, PCRBeckman Coulter develops, manufacturers and markets products that simplify,Contact:automate and innovate complex biomedical testing. Our diagnostic systemsDr. Gerhard Gunzerare found in hospitals and other critical care settings around the world andproduce information used by physicians to diagnose disease, make treatmentSauerbruchstr. 50decisions and monitor patients. Scientists use our life science research instrumentsto study complex biological problems including causes of disease andD-81377 MünchenPhone: +49 (0) 89 579589-0Fax: +49 (0) 89 579589-3503potential new therapies or drugs.E-Mail: info@beckmann.comHospital laboratories are our core clinical diagnostic customers. Our life sciencecustomers include pharmaceutical and biotechnology companies, universi-Internet: www.beckmanngenomics.comties, medical schools and research institutions. Beckman Coulter has an installedbase of more than 200,000 clinical and research systems operating inlaboratories around the world.Beckman Coulter has a leading position in Laboratory Automation. Research& Development as well as Production of our stand alone automation systems,the AutoMate 2500 Family (formerly known as OLA 2500), are located inMunich, Germany. 41
- Page 2 and 3: Our research benefits your health.T
- Page 4 and 5: ImprintEditorial staff: Georg Kää
- Page 6 and 7: Select IMGM as your outsourcing par
- Page 8 and 9: The 2011 Biotech Year in Bavaria -A
- Page 10 and 11: Due to this focus that was establis
- Page 12 and 13: Furthermore, the continued interest
- Page 14 and 15: Last but not least, the IZB start-u
- Page 16 and 17: Company FoundationsMerck-Sharp & Do
- Page 18 and 19: Total number of employees in the Ba
- Page 20 and 21: PHASE II4SC: Hepatocellular carcino
- Page 22 and 23: Deals, Cooperation, Mergers, Financ
- Page 24 and 25: M&A-ActivityIn early 2011 the acqui
- Page 26: Due to the increasing number of new
- Page 29: one so called “innovation allianc
- Page 32 and 33: 4SC AGBIOTECH THERAPEUTICS & DIAGNO
- Page 34 and 35: Contact:Dr. Luc St-OngeFraunhoferst
- Page 36 and 37: Contact:Dr. Lars WassillWerkstr. 2D
- Page 38 and 39: Apceth GmbH & Co. KGBIOTECH THERAPE
- Page 42 and 43: Bernina Plus GmbHBIOTECH THERAPEUTI
- Page 44 and 45: Biontex Laboratories GmbHBIOTECH DE
- Page 46 and 47: Carl Zeiss MicroImaging GmbHBIOTECH
- Page 48 and 49: ChemDiv, Inc.CROContact:Dr. Anna Ni
- Page 50 and 51: conoGenetix biosciences GmbHBIOTECH
- Page 52 and 53: CoreLab Partners Europe GmbHCROCont
- Page 54 and 55: Davids Biotechnologie GmbHBIOTECH D
- Page 56 and 57: Dynamic BiosensorsBIOTECH DNA/PROTE
- Page 58 and 59: Contact:Uschi LangGoethestr. 4D-803
- Page 60 and 61: Eurofins MWG OperonBIOTECH DNA/PROT
- Page 62 and 63: FGK Clinical Research GmbHCROContac
- Page 64 and 65: GeneArt AGBIOTECHContact:Prof. Dr.
- Page 66 and 67: Contact:Dr. Korbinian GroteBayerstr
- Page 68 and 69: Contact:Peter Paul SchikoraMühlfel
- Page 70 and 71: Contact:Kurt MartinJosef-Engert-Str
- Page 72 and 73: ibidi GmbHBIOTECH DEVICES & REAGENT
- Page 74 and 75: Immumed GmbH -Gesellschaft für ang
- Page 76 and 77: INHECO GmbHBIOTECH DEVICES & REAGEN
- Page 78 and 79: IRIS Biotech GmbHPHARMA & CHEMICAL
- Page 80 and 81: KLIFOVET AGCROContact:Dr. Klaus Hel
- Page 82 and 83: LEUKOCARE AGBIOTECH DEVICES & REAGE
- Page 84 and 85: medicomp GmbHCROContact:Dr. med. ve
- Page 86 and 87: Contact:Dr. Erwin SoutschekFlorians
- Page 88 and 89: MLL Münchner Leukämie Labor GmbHB
Contact:Dr. Gundel HagerBahnhofstr. 9-15D-82327 TutzingPhone: +49 (0) 8158 2597-30Fax: +49 (0) 8158 2597-31E-Mail: info@aurigon.deInternet: www.aurigon.deAurigon Life Science GmbHBIOTECH PRECLINICAL SERVICESKeywords: Toxicology, Pharmacology, Drug DevelopmentAurigon the CRO for efficacy and safety testing, is an independent, privatelyowned company dedicated to serving the biotech, pharmaceutical, food andchemical industries by providing a comprehensive range of services in bioanalytics,pharmacology, biological activity testing, ADME/PK and regulatorytoxicology (rodent and non-rodent) including genotoxicity, immunotoxicity,safety pharmacology, cancerogenicity and reprotoxicity. We have broadexperience in working with small molecules, chemicals and biologicals includingpeptides, antibodies, biosimilars, herbal extracts, nutritionals and celltherapy. With personalized and flexible services we support achievement ofour customers needs in expected timelines, investment and efforts. With itsheadquarter in the south of Munich, Aurigon Life Science operates in state ofthe art GLP respectively GMP compliant facilities with subsidiary andaffiliated laboratories located near Budapest. We are a trusted outsourcingpartner for multinational pharmaceutical and chemical groups, food producersand innovative biotechnology companies. We feel committed to life.baseclick GmbHBIOTECH DEVICES & REAGENTSContact:Dr. Thomas FrischmuthBahnhofstr. 9-15D-82327 TutzingPhone: +49 (0) 8158 903867Fax: +49 (0) 8158 903894E-Mail: info@baseclick.euInternet: www.baseclick.euKeywords: Clinical Diagnostics, Fine Chemicals / Reagents, New Materials,Chip / Array Technology, Nanobiotechnology, PCRbaseclick GmbH is a young and dynamic company funded and founded byBASF Venture Capital GmbH. The baseclick IP was generated at the Universityof Munich in the group of Prof. Thomas Carell. Core technology of ourcompany is the modification of nucleic acids via click chemistry. baseclickholds the IP for the technology and offers this for licensing, purchasing ofour products, and cooperation for the further development. We provideinnovative products to improve and enhance your research in the fields of:Oligonucleotide-, DNA- and RNA-labeling; PCR assays, cell proliferationassays, FISH probes and many more.Basilea Pharmaceutica Deutschland GmbHPHARMA & CHEMICAL INDUSTRYContact:Dr. Thomas TrillingKistlerhofstr. 75D-81379 MünchenPhone: +49 (0) 89 7857674-0Fax: +49 (0) 89 7857674-100E-Mail: office.DE@basileapharma.comInternet: www.basilea.com40Keywords: Drug Development, Antibiotics, Allergy, Dermatology, InfectiousDiseases, OncologyBasilea Pharmaceutica Ltd. is headquartered in Basel, Switzerland. Thecompany currently focuses on antibiotics and antifungal as well as oncologyand dermatology drugs, targeting the medical challenge of rising resistanceand non-response to current treatment options in the hospital and specialtycare settings. Basilea Pharmaceutica Deutschland was founded 2007 inMunich. Skin diseases are an area of high medical need. Patients aresuffering from disfiguring conditions such as hand eczema. Alitretinoin(Toctino ® ), a vitamin A derivative offers a significant quality of life improvementin the treatment of adults with severe chronic hand eczema unresponsiveto topical corticosteroid.
Change language